Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Biochemistry

• Publication date

  2006-04-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI052591HPMID 16605251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies.

  2005cited by this paper
• Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.

  2005cited by this paper
• Crystal structure of the E. coli dipeptidyl carboxypeptidase Dcp: further indication of a ligand-dependent hinge movement mechanism.

  2005cited by this paper
• Domain‐Selective Ligand‐Binding Modes and Atomic Level Pharmacophore Refinement in Angiotensin I Converting Enzyme (ACE) Inhibitors

  2005cited by this paper
• Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats.

  2005cited by this paper
• Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies

  2004cited by this paper
• What’s new in the renin-angiotensin system?

  2004cited by this paper
• Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs.

  2004cited by this paper
• ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis

  2004cited by this paper
• Crystal Structure of Human Thimet Oligopeptidase Provides Insight into Substrate Recognition, Regulation, and Localization*

  2004cited by this paper
• Structure of angiotensin I-converting enzyme.

  2004cited by this paper
• Isoforms of angiotensin I‐converting enzyme in the development and differentiation of human testis and epididymis

  2003cited by this paper
• Roles of the Two Active Sites of Somatic Angiotensin‐Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin Insights From Selective Inhibitors

  2003cited by this paper
• Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells.

  2003cited by this paper
• Crystal structure of Drosophila angiotensin I‐converting enzyme bound to captopril and lisinopril 1

  2003cited by this paper
• Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface.

  2003cited by this paper
• Ace revisited: A new target for structure-based drug design

  2003cited by this paper
• Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms.

  2003cited by this paper
• Monoclonal antibodies to denatured human ACE (CD 143), broad species specificity, reactivity on paraffin sections, and detection of subtle conformational changes in the C-terminal domain of ACE.

  2003cited by this paper
• Crystal structure of the human angiotensin-converting enzyme–lisinopril complex

  2003cited by this paper
• Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE.

  2003cited by this paper
• Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin‐converting enzyme

  2003cited by this paper
• Antibody-mediated lung endothelium targeting: in vivo model on primates

  2002cited by this paper
• Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface.

  2002cited by this paper
• Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus.

  2002cited by this paper
• Temperature‐induced selective death of the C‐domain within angiotensin‐converting enzyme molecule

  2002cited by this paper
• Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides.

  2002cited by this paper
• The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.

  2001cited by this paper
• [Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue].

  2001cited by this paper
• Structure of neurolysin reveals a deep channel that limits substrate access

  2001cited by this paper
• Human-chimpanzee DNA sequence variation in the four major genes of the renin angiotensin system.

  2000cited by this paper
• Isolation and characterization of the N-domain of bovine angiotensin-converting enzyme.

  2000cited by this paper
• CD143 in the development of atherosclerosis.

  2000cited by this paper
• Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors.

  2000cited by this paper
• A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.

  2000cited by this paper
• Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Antibody-mediated lung endothelium targeting: I. In vitro model using a cell line expressing angiotensin-converting enzyme

  1999cited by this paper
• RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

  1999cited by this paper
• Angiotensin-converting enzyme in non-neoplastic kidney diseases.

  1999cited by this paper
• Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.

  1998cited by this paper
• The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex.

  1998cited by this paper
• Angiotensin-converting enzyme and male fertility.

  1998cited by this paper
• Limited proteolysis of human kidney angiotensin-converting enzyme and generation of catalytically active N- and C-terminal domains.

  1997cited by this paper
• Membrane protein secretases.

  1997cited by this paper
• Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies

  1996cited by this paper
• Metalloprotease-mediated cleavage secretion of pulmonary ACE by vascular endothelial and kidney epithelial cells.

  1996cited by this paper
• Immunotargeting of antioxidant enzyme to the pulmonary endothelium.

  1996cited by this paper
• Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.

  1996cited by this paper
• Structure-Function Analysis of Angiotensin I-converting Enzyme Using Monoclonal Antibodies

  1994cited by this paper
• Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.

  1994cited by this paper
• Naturally occurring active N-domain of human angiotensin I-converting enzyme.

  1994cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.

  1992cited by this paper
• Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.

  1992cited by this paper
• Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene.

  1991cited by this paper
• Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes.

  1991cited by this paper
• The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

  1991cited by this paper
• Angiotensin-converting enzyme: new concepts concerning its biological role.

  1989cited by this paper
• Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.

  1989cited by this paper
• Radioimmunoimaging of lung vessels: an approach using indium-111-labeled monoclonal antibody to angiotensin-converting enzyme.

  1989cited by this paper
• Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

  1988cited by this paper
• Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane.

  1987cited by this paper
• A sensitive fluorimetric assay for serum angiotensin-converting enzyme.

  1976cited by this paper
• Studies on the angiotensin converting enzyme with different substrates.

  1970cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer’s Disease

  2024cites this paper
• ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation

  2024cites this paper
• Blood ACE Phenotyping for Personalized Medicine: Revelation of Patients with Conformationally Altered ACE

  2023cites this paper
• Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization

  2022cites this paper
• Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective

  2022cites this paper
• Human angiotensin I‐converting enzyme study by surface‐enhanced Raman spectroscopy

  2021cites this paper
• Epitope mapping of novel monoclonal antibodies to human angiotensin I‐converting enzyme

  2021cites this paper
• COVID-19-A theory of autoimmunity to ACE-2.

  2020cites this paper
• Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance

  2020cites this paper
• Interacting cogs in the machinery of the renin angiotensin system

  2019cites this paper
• Tissue ACE phenotyping in lung cancer

  2019cites this paper
• Conformational “Fingerprint” of the Angiotensin-Converting Enzyme

  2018cites this paper
• Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE)

  2017cites this paper
• Microfluidic single-cell technology in immunology and antibody screening.

  2017cites this paper
• Humanization of Murine Monoclonal anti-hTNF Antibody: The F10 Story

  2017cites this paper
• Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding

  2016cites this paper
• Conformational fingerprinting of angiotensin-converting enzyme in the blood in health and disease

  2016cites this paper
• Tissue Specificity of Human Angiotensin I-Converting Enzyme

  2015cites this paper
• A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP

  2014cites this paper
• Respiratory Regulation - The Molecular Approach

  2013cites this paper
• Immunotargeting of the pulmonary endothelium via angiotensin-converting-enzyme in isolated ventilated and perfused human lung.

  2013cites this paper
• Functional single-cell hybridoma screening using droplet-based microfluidics

  2012cites this paper
• Conformational Changes of Blood ACE in Chronic Uremia

  2012cites this paper
• An Angiotensin I-Converting Enzyme Mutation (Y465D) Causes a Dramatic Increase in Blood ACE via Accelerated ACE Shedding

  2011cites this paper
• Endothelial targeting of antibody-decorated polymeric filomicelles.

  2011cites this paper
• Targeted modulation of reactive oxygen species in the vascular endothelium.

  2011cites this paper
• Protein-protein interactions of human somatic angiotensin-converting enzyme

  2011cites this paper
• Fine epitope mapping of monoclonal antibodies 9B9 and 3G8 to the N domain of angiotensin-converting enzyme (CD143) defines a region involved in regulating angiotensin-converting enzyme dimerization and shedding.

  2010cites this paper
• Angiotensin I-Converting Enzyme Gln1069Arg Mutation Impairs Trafficking to the Cell Surface Resulting in Selective Denaturation of the C-Domain

  2010cites this paper
• Porcine pulmonary angiotensin I-converting enzyme--biochemical characterization and spatial arrangement of the N- and C-domains by three-dimensional electron microscopic reconstruction.

  2010cites this paper
• A further case of renal tubular dysgenesis surviving the neonatal period

  2009cites this paper
• Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects

  2009cites this paper
• Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects.

  2009cites this paper
• Angiotensin I-Converting Enzyme Mutation (Trp1197Stop) Causes a Dramatic Increase in Blood ACE

  2009cites this paper
• LIM domain protein TES changes its conformational states in different cellular compartments

  2008cites this paper
• Characteristics of monoclonal antibody binding with the C domain of human angiotensin converting enzyme

  2008cites this paper
• The antihypertensive effect of peptides: a novel alternative to drugs?

  2008cites this paper
• Simultaneous Determination of ACE Activity with 2 Substrates Provides Information on the Status of Somatic ACE and Allows Detection of Inhibitors in Human Blood

  2008cites this paper
• Mapping of conformational mAb epitopes to the C domain of human angiotensin I-converting enzyme.

  2008cites this paper
• Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood.

  2007cites this paper
• Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.

  2007cites this paper